Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Federal health advisers on Tuesday recommended approval for a highly anticipated cholesterol drug from Sanofi and Regeneron Pharmaceuticals, but with the caveat that more data is needed about its long-term ability to reduce heart attacks.
read more
The FDA has issued a draft guidance for industry, “Duchenne Muscular Dystrophy and Related Dystrophinopathies: Developing Drugs for Treatment,” to assist drug companies in the clinical development of drugs for the treatment of X-linked Duchenne ...
read more
LONDON (AP) — Protecting girls from cervical cancer might be possible with just one dose of the HPV vaccine rather than the three now recommended, a new analysis suggests.
read more
A new study published in Open Access journal PLOS Biology by the Global Biological Standards Institute (GBSI) and two leading economists estimates that, in the U.S. alone, approximately $28 billion per year is spent on preclinical research that is ...
read more
SACRAMENTO, Calif. (AP) — California lawmakers on Tuesday approved a hotly contested bill that would impose one of the strictest vaccination laws in the country, after five hours of highly emotional testimony that brought hundreds of opponents to the...
read more
Cardinal Health will spend about $1.12 billion to buy pharmaceutical distributor The Harvard Drug Group in a deal that aims to build its generic and over-the-counter drug businesses.
read more
Halozyme Therapeutics has announced its chief financial officer David Ramsay will retire this summer, and named biotech veteran Laurie Stelzer as his successor. Stelzer will assume CFO duties on June 15 and will work with Ramsay through a transition ...
read more
Eli Lilly has committed another 780,000 vials of insulin to the International Diabetes Federation's Life for a Child program.
read more
SmartLipo365 is voluntarily recalling 122 lots of Smart Lipo (800, 900, 950 mg) capsules, to the consumer level. FDA received samples of 800 and 900mg capsules of Smart Lipo and the lab results found the Smart Lipo products to contain undeclared ...
read more
WASHINGTON (AP) — The drug industry's decade-spanning search for a female equivalent to Viagra took a major step forward Thursday, as government experts recommended approval for a pill to boost sexual desire in women.
read more
The lawsuit was filed in response to an Abbreviated New Drug Application, or ANDA, filed by Actavis. In its application, Actavis seeks to market and sell generic versions of the currently approved doses of Contrave®.
read more
BioClinica®, Inc., has announced that David Peters, an accomplished senior finance and accounting executive, has been named Executive Vice President and Chief Financial Officer (CFO) and will be joining BioClinica on June 8, 2015.
read more
WASHINGTON (AP) — President Barack Obama's effort to curb the use of antibiotics in animals raised for meat is starting with his own employees.
read more
Accuratus Lab Services and its principal owner, Ampersand Capital Partners, have announced the acquisition of the chemistry, manufacturing and controls (CMC) operation of Array BioPharma.
read more
AmerisourceBergen has announced plans to build three new distribution centers in Olive Branch, MS; Shakopee, MN; and Newburgh, NY.
read more